Compass Pathways: Independent Media Talks Psychedelic Medicine

In this episode of Divergent States, we sit down with Kabir Nath, CEO of Compass Pathways, and Dr. Steve Levine, Chief Patient Officer, to talk about the future of psychedelic medicine. From FDA approval and insurance coverage to patient access, cultural safety, and patents, we dig into whether Compass is truly disrupting the pharma model or just reinventing it.

We also share a major community update: the official Divergent States Discord is now open to all of r/Psychonaut. Built by Brady and the mod team, the server is a space for harm reduction, trip reports, deep dives, and authentic connection across the psychedelic movement.

As always, this conversation is about asking the real questions without corporate PR filters. What Compass shared — and what they left unsaid — reveals as much about the future of psilocybin therapy as the answers themselves.

👉 Join the movement: connect on Discord, support independent media on Patreon, and be part of the conversation. 

https://discord.gg/swPwT6ZYun

Key Points

• FDA approval: path to affordability or illusion of access?
• COM360 psilocybin therapy: synthetic model, patient journey, and therapy debate
• Access & equity: insurance hurdles, pricing models, and patient foundations
• Cultural safety: trauma-informed design, marginalized populations, indigenous roots
• Patents & Pharma tension: innovation vs. corporate control in psychedelic medicine
• Community news: Divergent States Discord officially launches for r/Psychonaut

Chapters

 00:00 – Intro: Setting the frame for Compass Pathways
 01:30 – Community Update: Divergent States Discord opens for r/Psychonaut
 09:30 – Guest Intros: Kabir Nath & Dr. Steve Levine of Compass Pathways
 11:20 – Kabir on moving from pharma to psychedelics
 12:30 – Steve on ketamine clinics & new models of care
 14:15 – What “success” looks like for patients
 16:00 – COM360 psilocybin therapy: synthetic vs. natural & the role of therapy
 17:30 – How Compass plans to deliver psilocybin in different care settings
 18:40 – Patient hopes, fears, and the path to access
 20:00 – FDA approval, insurance, and affordability
 21:00 – Cultural safety, trauma-informed design, and community input
 21:45 – Indigenous engagement & staying “in their lane”
 24:15 – The next 5–10 years of psychedelic treatment
 26:10 – What could derail psychedelic medicine’s promise
 28:10 – Compass’ place in the broader psychedelic ecosystem
 29:50 – Outro: Independent media reflections & listener call to action 

New Music from Sndbagz - check out his new EP "Chosen Path" on Soundcloud and Spotify

https://open.spotify.com/artist/0T1LU2nJ9ibGIU3Bxin2X6
https://soundcloud.com/user-918755844

FiresideProject.org

Download the app or text/call 62-FIRESIDE

Zendo Project
Our listeners get 10% off the Zendo Project SIT Program with the code DIVERGENTS10

Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.